- Our state of the art R&D facilities are spread over 35,000 sft
- Our New Product Capabilities are in :
- Parenteral depot formulations
- Sterile emulsions & suspensions
- Complex to develop and characterize products
- Selected oral dosage forms
- Lipid drug delivery
- Microsphere based products
- Nanotechnology based products
No comments:
Post a Comment